SPARK creates a unique, nonprofit model to address Stanford’s mission in research and education.

Stanford must prepare its students, postdoctoral fellows, and faculty to address the future challenges of health care, whether through academic medicine, clinical practice, or industry. SPARK’s educational program teaches participants the technical know-how required to advance early programs to the clinical stage. Mentoring is provided by advisors with expertise in product development, clinical care, and business, preparing participants for careers that link investigation with important new therapies.

The Department of Chemical and Systems Biology hosts many of the courses on the drug development process. To learn more about the department or enrolling in Stanford to learn about drug development, please visit their website.

Class Notes

  • CSB 240 A/ B - A Practical Approach to Drug Discovery and Development (SUNet ID required):
    Description:  Advancing a drug from discovery of a therapeutic target to human trials and commercialization.  Topics include: high throughput assay development, compound screening, lead optimization, protecting intellectual property, toxicology testing, regulatory issues, assessment of clinical need, defining the market, conducting clinical trials, project management, and commercialization issues, including approach to licensing and raising capital.
    Two-term Series (Win & Spr) alternating years | Units: 3 | Next offered 2013
  • CSB 242 - Drug Discovery and Development Seminar Series:
    Description:  Attend SPARK biweekly meetings to hear project updates or seminars on drug development topics presented by industry experts.
    Win, Spr | Units: 1 | Offered every year
  • CSB 244 : Drug Discovery and Development: A Case-Based Approach 
    Description:  Introductory course covering the basics of drug discovery and development. Topics inlcude target identification and validation; identification of small molecule compounds that modualte the target of interest; properties of a drug development candidate; drug formulation, absorption, and pharmacokinetics; preclinical safety studies; drug manufacturing and quality assurance; human testing for safety and efficacy; and regulatory issues. Chemical and Systems Biology students may not take this class for credit in addition to CSB 240A.
    Spr | Units: 3

Stanford Medicine Resources:

Footer Links: